EPINFLAM

Epithelial cells in inflammation

 Coordinatore UNIVERSITAET ZU KOELN 

Spiacenti, non ci sono informazioni su questo coordinatore. Contattare Fabio per maggiori infomrazioni, grazie.

 Nazionalità Coordinatore Germany [DE]
 Totale costo 2˙500˙000 €
 EC contributo 2˙500˙000 €
 Programma FP7-IDEAS-ERC
Specific programme: "Ideas" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call ERC-2012-ADG_20120314
 Funding Scheme ERC-AG
 Anno di inizio 2013
 Periodo (anno-mese-giorno) 2013-05-01   -   2018-04-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITAET ZU KOELN

 Organization address address: ALBERTUS MAGNUS PLATZ
city: KOELN
postcode: 50923

contact info
Titolo: Mrs.
Nome: Silke
Cognome: Rohn
Email: send email
Telefono: +49 221 4705498
Fax: +49 221 4704984

DE (KOELN) hostInstitution 2˙500˙000.00
2    UNIVERSITAET ZU KOELN

 Organization address address: ALBERTUS MAGNUS PLATZ
city: KOELN
postcode: 50923

contact info
Titolo: Prof.
Nome: Manolis
Cognome: Pasparakis
Email: send email
Telefono: +49 221 4701526
Fax: +49 221 4705163

DE (KOELN) hostInstitution 2˙500˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

regulating    dysbiosis    cells    ibd    autophagy    talk    revealed    mutations    paneth    inflammation    inflammatory    microbiota    pathways    cross    chronic    epithelial    genes    host    pathogenesis    death    nod    defences    integrity    antibacterial    cell    barrier    intestinal    additional   

 Obiettivo del progetto (Objective)

'The cross talk between the host and the microbiota is believed to be the major determinant of health and disease in the gastrointestinal tract. Inflammatory bowel diseases (IBD) are chronic inflammatory conditions of the intestine with unclear aetiology. Deregulation of the cross talk between the intestinal microbiota and the host immune system is considered a main factor contributing to IBD. Genomic studies revealed associations of NOD2 and of genes regulating autophagy and ER stress with an increased risk for IBD. Mutations in these pathways compromise Paneth cell dependent epithelial antibacterial defences causing alterations in the intestinal microbiota, termed dysbiosis. However, mutations in NOD2 or autophagy genes are not sufficient to cause intestinal inflammation in humans or in mice, suggesting that dysbiosis by itself cannot cause inflammation but additional, as yet unidentified, factors are required to precipitate the pathogenesis of IBD in genetically susceptible individuals. Mouse model studies revealed that epithelial specific mutations sensitizing intestinal epithelial cells to apoptosis or necroptosis triggered spontaneous intestinal pathologies with many features of human IBD, including loss of Paneth cells, impaired epithelial antimicrobial defences and chronic intestinal inflammation. We hypothesize that pathways controlling programmed cell death critically contribute to the pathogenesis of IBD by acting on Paneth cells to regulate epithelial antibacterial defences and simultaneously regulating intestinal epithelial cell survival and the integrity of the epithelial barrier. The aims of this research proposal are: a) to dissect the pathways regulating Paneth cell death and the development of dysbiosis in the gut, and b) to elucidate the additional genetic or environmental factors regulating intestinal epithelial barrier integrity that are likely to synergise with Paneth cell dysfunction and dysbiosis to trigger chronic intestinal inflammation.'

Altri progetti dello stesso programma (FP7-IDEAS-ERC)

BIOTIME (2010)

Biological diversity in an inconstant world: temporal turnover in modified ecosystems

Read More  

NANOSENSOMACH (2011)

Nanoengineered Nanoparticles and Quantum Dots for Sensor and Machinery Applications

Read More  

ZF-DELIVERY (2014)

ZF-Delivery

Read More